Paloma Partners’s VIVEVE MED INC VIVE Stock Holding History

Paloma Partners’s Portfolio VIVE Stock Details VIVE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-99	Closed	-$268K	–	2048
2018 Q2	$268K	Buy	+99	New	+$285K	﹤0.01%	1334

Other funds holding VIVE

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

SCM

Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Polar Capital London, United Kingdom $13.5B AUM 55.9% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

MIH

Meitav Investment House Bene-Beraq, Israel $9.12B AUM 42.07% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Paloma Partners's VIVE Position: Q3 2018 in Review

Paloma Partners sold out of VIVEVE MED INC (VIVE) in Q3 2018, closing a stake of 99 shares — an estimated $268K sold.

Paloma Partners first reported a position in VIVE in Q2 2018 and held it in 1 quarter. The position peaked at $268K in Q2 2018. 36 funds tracked by Wall St. Rank hold VIVE as of Q3 2018.

Paloma Partners reported no remaining VIVEVE MED INC position as of Q3 2018 after selling out during the quarter.
Paloma Partners sold 99 VIVEVE MED INC shares in Q3 2018, an estimated $268K.
Paloma Partners first reported a position in VIVEVE MED INC in Q2 2018 and held it in 1 quarter.
Paloma Partners's VIVEVE MED INC position peaked at $268K in Q2 2018.
36 funds tracked by Wall St. Rank held VIVEVE MED INC as of Q3 2018.

Based on Paloma Partners's 13F filing for Q3 2018, filed 14 Nov 2018.